Ohio Public Employees Retirement System (OPERS)’s AEON Biopharma AEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,045
Closed -$756K 1987
2022
Q4
$756K Hold
1,045
﹤0.01% 1215
2022
Q3
$741K Hold
1,045
﹤0.01% 1268
2022
Q2
$738K Buy
1,045
+351
+51% +$248K ﹤0.01% 1298
2022
Q1
$489K Buy
+694
New +$487K ﹤0.01% 1344

Other funds holding AEON

Ohio Public Employees Retirement System (OPERS)'s AEON Position: Q1 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 1,045 shares — an estimated $756K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in AEON in Q1 2022 and held it in 4 quarters. The position peaked at $756K in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,045 AEON Biopharma shares in Q1 2023, an estimated $756K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in AEON Biopharma in Q1 2022 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s AEON Biopharma position peaked at $756K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2023, filed 15 May 2023.